Program
TBSI2014 Program
Print Full program| Time | Session/Lecture info |
|---|---|
| 14:00-17:30 | Registration (Please present photo ID)
|
| 14:00-17:30 | |
| 17:30-21:30 | OPENING OF SYMPOSIUM
Chair: Luke O'Neill |
| 17:30-17:50 |
Mary Daly, President of the Royal Irish Academy
Welcome address
|
| 17:50-18:20 |
James Watson, CSH,USA
Keynote Nobel presentation 1: Cancer is a Redox Disease
|
| 18:20-18:50 |
Douglas Golenbock, UMass, USA
Special guest speaker: DNA recognition drives the innate immune response in malaria
|
| 18:50-19:20 |
Aaron Ciechanover, Technion, Israel
Keynote Nobel presentation 2: The ubiquitin proteolytic System: From discovery through basic mechanisms, and on to human diseases and drug targeting
|
| 19:20-20:15 |
Drinks Reception
|
| Time | Session/Lecture info |
|---|---|
| 08:00-09:00 | Registration (Please present photo ID)
Breakfast with Nobel Laureates - selected invitees |
| 08:00-09:00 | |
| 09:00-09:30 | Jules Hoffmann, IBMC, France
Keynote Nobel Presentation 3 (Introduced by Douglas Golenbock) The Drosophila immune defense: a paradigm for innate immunity |
| 09:00-09:30 | |
| 09:30-11:40 | Session 1: Immunology/Inflammation I
Chair: Idit Shachar |
| 09:30-09:55 |
Luke O'Neill, TBSI
Metabolic reprogramming in innate immunity
|
| 09:55-10:20 |
Ido Amit, Weizmann Institute of Science
Unbiased characterization of the immune system using massively parallel single cell RNA-Seq.
|
| 10:20-10:45 |
Andrew Bowie, TBSI
Viruses and innate immunity: sensing, signaling and subversion
|
| 10:45-11:10 |
David Wallach, Weizmann Institute of Science
Regulation of immune response by signaling proteins activated by the TNF family
|
| 11:10-11:40 |
Break
|
| 11:40-14:30 | Session 2: Immunology/Inflammation II
Chair: Steffen Jung |
| 11:40-12:05 |
Orla Hardiman, TBSI
Finding treatments for ALS Why aren?t we there yet?
|
| 12:05-12:30 |
Idit Shachar, Weizmann Institute of Science
Molecular Mechanisms Regulating B cell survival in Health and Disease
|
| 12:30-12:55 |
Cliona O´Farrelly, TBSI
Resistance and Susceptibility to HCV infection: Immunology lessons from an Irish Cohort
|
| 12:55-13:30 |
Special Guest Speaker: Marc Feldmann, Oxford, England
(Introduced by David Wallach)
Beyond anti TNF therapy for rheumatoid arthritis: Can we get closer to a cure? |
| 13:30-14:30 |
Break
|
| 14:30-16:35 | Session 3: Immunology/Inflammation III
Chair: Andrew Bowie |
| 14:30-14:55 |
Eran Elinav, Weizmann Institute of Science
Neighborly relations- host-microbiota interactions in health and disease
|
| 14:55-15:20 |
Kingston Mills , TBSI
The interface between innate and adaptive immunity?
|
| 15:20-15:45 |
Yehuda Kamari, Sheba Medical Center
The Role of Interleukin-1α in Metabolic Inflammation
|
| 15:45-16:00 |
Padraic Fallon, TBSI
Innate cell priming of adaptive inflammatory diseases
|
| 16:00-16:35 |
Break
|
| 16:35-21:30 | Session 4: Immunology/Inflammation IV
Chair: David Wallach |
| 16:35-17:00 |
Aisling Dunne, TBSI
Inflammasome activation, from infection to inflammatory disease
|
| 17:00-17:25 |
Steffen Jung, Weizmann Institute of Science
Macrophage Contributions to Gut and Brain inflammation
|
| 17:25-17:50 |
Alan Irvine, TCD
Early mechanisms in atopic disease: genetic and functional insights
|
| 17:50-18:20 |
Bruce Beutler, Texas
Keynote Nobel Presentation 4
(Introduced by Eran Elinav) Finding genes that affect immunity by “real time” positional cloning |
| 18:20-20:00 |
Reception, Knowledge Exchange Room
|
| Time | Session/Lecture info |
|---|---|
| 08:00-09:00 | Registration (Please present photo ID)
Breakfast with Nobel Laureates - selected invitees |
| 08:00-09:00 | |
| 09:00-09:30 | Ada Yonath, Weizmann Institute of Science
Nobel Presentation 5 (Introduced by Martin Caffrey) Combating species-specific antibiotics resistance? |
| 09:00-09:30 | |
| 09:30-11:30 | Session 5: Cancer and anti-cancer therapy I
Chair: Eran Elinav |
| 09:30-09:55 |
Yossi Yarden, Weizmann Institute of Science
Roles for growth factors and receptor tyrosine kinases in tumor progression and in cancer therapy
|
| 09:55-10:20 |
Martin Caffrey, TBSI
A marvelous mesophase
|
| 10:20-10:45 |
Ashraf Brik, Ben Gurion University
Chemical Biology with Deubiquitinases
|
| 10:45-11:10 |
Seamus Martin, TCD
Inflammatory Outcomes from Cell Death Signals
|
| 11:10-11:30 |
Break
|
| 11:30-14:20 | Session 6: Cancer and anti-cancer therapy II
Chair: Yossi Yarden |
| 11:30-11:50 |
Paul Browne, TCD
Immunophenotyping and haematological neoplasms
|
| 11:50-12:10 |
John O’Leary, TCD
New insights into the metastatic cascade: where cancer and immunology meet
|
| 12:10-12:30 |
Yinon Ben-Neriah, Hebrew University
Parainflammation effects in cancer
|
| 12:30-12:50 |
Thorfinnur Gunnlaugsson, TCD
Targeting cancer cells with supramolecular nanotechnology: The use of luminescent ruthenium polypyridyl complexes and gold nanoparticles
|
| 12:50-13:10 |
Gavin Davey, TBSI
Targeting mitochondrial fusion/fission dynamics in tumor cells
|
| 13:10-13:30 |
Irit Sagi, Weizmann Institute of Science
Controlling extracellular remodeling as a strategy to fight inflammatory diseases and cancer
|
| 13:30-14:20 |
Break
|
| 14:20-17:30 | Session 7: Technology Transfer-reaping the benefits of outstanding research
Chair: Kingston Mills |
| 14:20-14:50 |
Mark Ferguson, Director General, Science Foundation Ireland
Impact from excellent research: programs, metrics and international benchmarking of small advanced nations
|
| 14:50-15:20 |
Mudi Sheves, The Weizmann Institute’s vice president for technology transfer
The Weizmann Institute of Science for the Benefit of Society: Technology Transfer Mechanism
|
| 15:20-16:50 |
Diarmuid O’Brien, Director of Trinity Research and Innovation
Commercialization of intellectual properties at TBSI
|
| 16:50-17:10 |
Ruth Arnon, President of the Israeli Academy of Science and Humanities
The contribution of the academia in Israel to society and the economy
|
| 17:10-17:30 |
Tom Lynch, Chair of Board, TBSI
Closing Drinks Reception sponsered by NASConnect (invitation only)
|